RxAll

company

About

RxAll is a Deep Learning-Hyperspectral IoT Platform for the authentication and real-time global tracking of quality of drugs.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$2M
Industries
Artificial Intelligence,Big Data,Database,Delivery Service,Enterprise,Hardware,Internet of Things,Software
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

RxAll is a Deep Learning-Hyperspectral IoT Platform for instant authentication and real-time global tracking of quality of drugs- prescription & OTC meds., opioids, recreational drugs and cannabis- through mobile phones and a cloud based platform. We deliver authenticated medicines to hospitals, pharmacies and patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$2.80M
RxAll has raised a total of $2.80M in funding over 2 rounds. Their latest funding was raised on Nov 10, 2020 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 10, 2020 Convertable Note 1 Detail
Feb 17, 2020 Seed $2M 1 Detail
Sep 30, 2019 Pre-seed $745.13K 1 Detail
Aug 31, 2017 Grant $60K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
RxAll is funded by 2 investors. HAX and Equilateral Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
HAX Convertable Note
Equilateral Ventures Grant